Cadence vs Verily
Two supervised agent models for chronic care, sold to different buyers. Cadence partners with health systems and runs chronic care management for older adults at home, monitoring daily vitals for hypertension, diabetes, heart failure and lung disease, and it publishes the disclosure this category almost never offers: the proportion of vitals alerts its agents resolve without a human, with a stated review time beside it. Verily sells to health plans, employers and pharmacy benefit managers, with agents triaging and escalating members to a clinical team, a credible certification set and a health privacy structure better designed than most consumer facing arrangements in this index. The split is contractual rather than technical. If the buyer is a provider organisation billing chronic care management, Cadence. If it is a plan or employer managing a metabolic population, Verily.
- It publishes the number this category never publishes: 55 percent of vitals alerts resolved autonomously, alongside a stated review time, which turns a supervised agent claim into something a buyer can audit.
- The peer reviewed publication record is real and cited on the vendor's own site across recognised journals, which is rare for a chronic care management service.
- The population and conditions are enumerated rather than described: older adults at home with hypertension, type 2 diabetes, heart failure and chronic obstructive pulmonary disease.
- The escalation design is the product rather than a fallback, with agents triaging and escalating members to a clinical team, and the commitments are published in language a member can actually read.
- The health privacy structure is materially better designed than the patient directed arrangements this index records elsewhere, and the certification set is credible with a dedicated trust page.
- Retrieval breadth is real and honestly bounded, with the affiliated clinical entity gathering records with member consent and the limits of that stated rather than glossed.
Side by Side
| Axis | C Cadence |
V Verily |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
Both wrap software around a clinical service, so a buyer is purchasing labour as well as models and should price it that way. Cadence publishes no security attestation, trust centre, retention position, training use statement or hosting detail, and its deep record system integration is claimed without a marketplace listing or integration documentation. Verily names its products and agents but not the technology beneath them, and publishes no governance framework or model documentation.
Neither publishes subgroup performance, which matters in remote monitoring because device adherence and connectivity vary sharply with income, age and housing, and a patient whose readings stop arriving looks identical to a patient who is well.